Matin
9 h 00 Ouverture de la Session
F. Fontan, J.J. Pastor, V.Dor
Insuffisance cardiaque (I.C) : une entité ?
Modérateurs : G. Kirkorian (Lyon, France), M. Sabatier (C.C.Monaco)
9 h 05
I.C : épidémiologie et prévalence :
impact sur la population au 21e siècle.
J. Young, USA, Cleveland Clinic Foundation
9 h 35 Bilan non invasif de l’
I.C
N. Banner (Londres, Royaume-Uni)
9h 55 Traitement médical de l’
I.C
S. Marra (Torino, Italie)
10 h 20 Nouvelles molécules dans le traitement de l’
I.C
M. Gheorghiade (Chicago, USA)
10 h 35 Pause Café
Modérateurs : P.Touboul (Lyon, France), F.Bourlon (C.C.Monaco)
10 h 50 Resynchronisation et défibrillateur implantable dans l’
I.C
:
indications et résultats
G. Kirkorian (Lyon,France)
11 h 15 I.C diastolique
E. Gronda (Milano, Italie)
11 h 40 “CorAssist Devices for Modulation of Diastolic LV Dysfunction”
L. Lak &/or A. Elami (Israel)
11 h 55 Discussion
12 h 15 Déjeuner au Centre Cardio-Thoracique de Monaco
Morning
9:00 Opening session
F. Fontan, J.J. Pastor, V. Dor
Congestive Heart Failure (C.H.F): as an entity ?
Chairpersons : G. Kirkorian (Lyon, France), M. Sabatier (C.C.Monaco)
9:05 C.H.F, Epidemiology, prevalence: impact on the population in
the 21st Century
J. Young, USA, Cleveland Clinic Foundation
9:35 Non invasive assessment in C.H.F
N. Banner (London, UK)
9:55 Medical treatment of C.H.F
S. Marra (Torino, Italy)
10:20 New molecules in the treatment of C.H.F
M. Gheorghiade (Chicago, USA)
10:35 Coffee break
Chairpersons : P.Touboul (Lyon, France), F.Bourlon (C.C.Monaco)
10:50 Resynchronisation and implantable defibrillator therapy in C.H.F –
indication & results
G. Kirkorian (Lyon,France)
11:15 Diastolic H.F
E. Gronda (Milano, Italy)
11:40 CorAssist Devices for Modulation of Diastolic LV Dysfunction
L. Lak &/or A. Elami (Israel)
11:55 Discussion
12:15 Lunch at the Centre Cardio-Thoracique de Monaco
Afternoon
Congestive Heart Failure (C.H.F): as a symptom ?
Chairpersons : F. Robicsek, F. Civaia (C.C.Monaco)
Introduction
2:30 Valvular induced H.F, treat the cause,
V. Dor
2:35 Mitral regurgitation in C.H.F : is there a role for surgery
G. Dreyfus (London, UK)
2:55 Idiopathic or primitive cardiomyopathies :
classification and evolution
M. Sabatier (C.C.Monaco)
3:05 Non invasive evaluation by MRI of C.H.F in non ischemic
cardiomyopathies
S. Prasad (London, UK)
3:20 Amyloid cardiomyopathy : aetiopathogenesis, diagnosis and
treatment
M. Pepys (London, UK)
3:50 Decompensated or acute heart failures, mechanical supports and H.T.
G. Dreyfus (London, UK)
4:05 Coffee break
Chairpersons : F.Fontan, P.Rossi (C.C.Monaco)
4:20 Why Ischemic HF differs from other CHF types? Specificities and
prevalence. Role of coronary revascularization
M. Di Donato (Firenze,Italy)
4:45 After or before coronary revascularization, look at the LV wall
F. Civaia (C.C.Monaco)
5:00 If localized extended scar, treat the cause : the left ventricular
reconstruction
V. Dor
Interventions
5:15 San Donato Milanese experience L.Menicanti (Milano, Italy)
5:25 Heart transplantation in ischemic C.H.F
R.Ferrazzi (Bergamo, Italy)
5:35 End stage ischemic cardiomyopathy : heart transplantation
or repair, V.Dor
5:45 Discussion
6:00 Organization of an efficient Heart Failure Center
J. Young, USA, Cleveland Clinic Foundation
6:30 End of Session
43669027-depliant 12/08/09 11:49 Page 1